Piper Sandler Just Hiked Humana Target to $254
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesPiper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Eight years, 25 properties, 35 units. This is the real-world story behind deal diaries: cameron philgreen, a Texas in...
Labor data now leads mortgage rates, shifting focus from inflation headlines. Markets await Jobs Friday to gauge the ...
If SpaceX goes public, investors will chase big headlines and big moves. History suggests year-one volatility is the ...
When rental markets get crowded, concessions can tilt the odds toward a signed lease. This practical guide explores w...
I once believed SpaceX would be a slam-dunk winner for investors. Then I realized a careful, staged approach beats ri...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
Suncor Energy has climbed sharply this year, but is the rally justified for new buyers? This guide breaks down the dr...
When the market wobbles, a simple, cost-effective ETF strategy can power your long-term plan. This article explains w...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...